Resultado busqueda pregunta 3

Recently Added Items

Title Added By Updated On
Ximelagatran: The future in anticoagulation practice? ccampos.hugf Apr 2, 2012 3:02:59 PM
Warfarin may reduce the risk of stroke, but increases major bleeding compared with aspirin in non-valvular atrial fibrillation ccampos.hugf Apr 2, 2012 3:02:59 PM
Vitamin K antagonists and direct thrombin inhibitors: Present and future ccampos.hugf Apr 2, 2012 3:02:59 PM
Updates on new oral anticoagulants and percutaneous devices for stroke prevention in patients with non-valvular atrial fibrillation ccampos.hugf Apr 2, 2012 3:02:59 PM
Update on pharmacologic approaches to prevent thromboembolism in atrial fibrillation: Are thrombin and factor Xa inhibitors the ultimate answer? ccampos.hugf Apr 2, 2012 3:02:59 PM
Stroke prevention using the oral direct thrombin inhibitor ximelagatran in patients with non-valvular atrial fibrillation: Pooled analysis from the SPORTIF III and V studies ccampos.hugf Apr 2, 2012 3:02:59 PM
Safety and tolerability of YM150 in subjects with non-valvular atrial fibrillation: A phase II study ccampos.hugf Apr 2, 2012 3:02:59 PM
Safety and tolerability of the oral factor Xa inhibitor, YM150 vs. warfarin in 1297 patients with nonvalvular atrial fibrillation: A dose confirmation study (OPAL-2) ccampos.hugf Apr 2, 2012 3:02:59 PM
Preventing stroke in atrial fibrillation: The SPORTIF programme ccampos.hugf Apr 2, 2012 3:02:59 PM
Predictors of major bleeding risk: Insights from the rivaroxaban once-daily oral direct factor XA inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (Rocket AF) ccampos.hugf Apr 2, 2012 3:02:59 PM

See all 161 items for this group in the Group Library.

Recent Group Discussion

No recent group discussions.

Resultado PubMed y EMBASE pregunta 3 (99 referencias)

Members (1)

ccampos.hugf

Menu